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RECEIVED DATE (to be automatically inserted after your manuscript is accepted if 
required according to the journal that you are submitting your paper to) 
Abstract: An unexpected ring-opening of 3-aminobenzofurans promoted by NaOtBu in hot toluene, leading to a variety 
of -ketoimines is described. In the presence of 3-iodobenzofurans, NaOtBu mediates the 3-aminobenzofurans ring-
opening via a possible radical pathway without the help of any external radical sources. 
INTRODUCTION 
Combretastatin A-4 (CA-4, Figure 1) is a natural 
microtubule destabilizing drug, able to damage the 
vasculature cancer tumors causing central necrosis.1 
Recently, Food and Drug Administration (FDA) has 
granted orphan drug designation to its prodrug CA-4 
phosphate (CA-4P) for the treatment of glioblastoma 
multiform and neuroendocrine tumors.2  
 
FIGURE 1. Representative Vascular Disrupting Agents 
and Rational Drug Design from CA-4 to isoCoQuin 
Derivatives 1 
Although effective in antitumor therapy, CA-4 is not 
stable since its Z-double bond isomerizes during storage 
and administration leading to a 100-fold less active E-
stilbene. This problem was solved in our group by the 
discovery of isoCombretastatin A-4 (isoCA-4), and other 
analogues3 including, azaisoerianin and various quinoline 
derivatives as isoCoQuin. For instance, isoCoQuin in 
which a quinaldine replaced the 3,4,5-trimethoxyphenyl 
A-ring of isoCA-4 has demonstrated low nanomolar 
potency against diverse tumor models and displayed 
antivascular properties identical to those of CA-4 and 
isoCA-4. Our studies around isoCoQuins were furthered 
to design, synthesize, and evaluate a novel panel of 
compounds of type 1 containing a benzofuran as B-ring 
encountered in BNC105,4 a potent tubulin polymerization 
inhibitor. 
Initially, we applied efficient Buchwald-Hartwig 
coupling conditions,5 for the coupling reaction of 4-
aminoquinaldine 2a with 3-iodobenzofuran 3a (R = Ph) 
to provide 4a using Pd2dba3 as the catalyst, XPhos as the 
ligand, NaOtBu as the base in hot toluene (Scheme 1). 
Surprisingly, the desired 4a was not detected and, 
instead, (Z)-α-ketoimine 5a, was obtained in 70% yield 
and evidenced by 1H-NMR6 and mass spectrometry. 
However by replacing sodium tert-butoxide (NaOtBu) by 
cesium carbonate (Cs2CO3), we were pleased to observe 
the formation of 4a, which turned out to be unstable7 and 
was rapidly N-methylated, using NaH and CH3I providing 
1a in 47% yield (two steps). Using these experimental 
conditions, targeted compounds 1b and 1c were 
synthesized and their antiproliferative activity was 
investigated against HCT116 human colon tumor cell 
lines. However, biological results revealed that 
compounds 1a-c exhibited a micromolar level of 
cytotoxicity, which was not sufficient to consider other 
structural modifications in this chemical series (see SI). 
 SCHEME 1. Formation of Ketoimine 5a or isoCoQuins  
1a-c from the Coupling of 2a with 3 
 
Next, we focused our attention on the intriguing 
formation of -ketoimines of type 5. Although being 
interesting intermediates in synthetic organic reactions, 
the synthesis of -ketoimines is, however, poorly 
documented8 and in particular those of compounds 5, 
which has never been reported. In this article we report 
the first 3-aminobenzofurans ring-opening9 leading to α-
ketoimines 5 under Buchwald-Hartwig coupling 
conditions. 
RESULTS AND DISCUSSION 
We began our investigations to increase the chemical 
yield in α-ketoimine 5b (Table 1) using p-anisidine 2b 
and 3-iodobenzofuran 3b as model substrates (47%, entry 
1). A total conversion was observed and compound 5b 
was isolated in 85% yield (entry 2) using an excess of 
NaOtBu (5 equiv), demonstrating that the base played a 
major role in the benzofuran ring-opening. We noted that 
replacing NaOtBu by LiOtBu and KOtBu (10 equiv) 
furnished 5b but with lower yields (25 and 60%, resp., 
entries 6 and 7), probably because the Buchwald 
coupling reaction was less efficient using these bases. 
Subsequently, the screening reaction conditions with 
respect to the phosphine ligand was investigated and 
revealed that, on the contrary to BINAP (L3), Xphos (L2) 
gave a comparable result with the one obtained with the 
bulky bidentate phosphine Xantphos (L1) providing 5b in 
92% yield (entry 11). Finally, after screening other 
parameters (solvent, temperature and reaction time), our 
optimal conditions were found to require 2b (1 equiv), 3b 
(1.1 equiv), Pd2dba3 (5 mol %), Xphos (10 mol %), 
NaOtBu (5 equiv), in toluene in a sealed Schlenk tube at 
140 °C for 16 h.  
FIGURE 2. X-Ray Structure of 5b 
 
TABLE 1. Evaluation of Reaction Parametersa 
 
Entry Ligand Baseb Equiv 
of base 
Solvent T (°C) Yield 
(%)c 
1 L1 NaOtBu 2.2 Toluene 130 47 
2 L1 NaOtBu 5 Toluene 130 85 
3 L1 NaOtBu 10 Toluene 130 83 
4 L1 NaOtBu 5 Toluene 140 89 
5 L1 NaOtBu 5 Toluene 150 88 
6  L1 LiOtBu 10 Toluene 140 25 
7 L1 KOtBu 10 Toluene 140 60 
8 L1 NaOtBu 5 Dioxane 140 32 
9 L1 NaOtBu 5 DMAc 140 traces 
10 L1 NaOtBu 5 NMP 140 traces 
11 L2 NaOtBu 5 Toluene 140 92 
12 L3 NaOtBu 5 Toluene 140 35 
aConditions: 2b (1 equiv), 3b (1.1 equiv), Pd2dba3 (5 mol 
%), L (10 mol %), base, solvent (3 mL), Schlenk tube, 16 h. 
b Other bases as NaOMe, NaOEt, K2CO3, Na2CO3, K3PO4 
and LiHMDS were evaluated under the condition of entry 4 
but without any success as 2b and 3b were mainly found 
unchanged. cYield of isolated product. 
As control experiments, when the reaction was achieved 
in the absence of NaOtBu (or Pd2dba3 or XPhos), no 
reaction occurred and starting materials 2b and 3b 
remained unchanged. One can note that after 
recrystallization of 5b in dichloromethane/diethyl ether 
mixture (10:90), the structure of the ketoimine product 
(Z)-5b was confirmed by X-ray analysis (Figure 2).With 
these optimized conditions in hands, we then proceeded 
to investigate the scope of this transformation using 
various 3-iodobenzofurans 3 and aromatic amines 2. As 
can be seen in Scheme 2, employing a variety of 
electron-rich anilines with 3-iodo-2-phenylbenzofurans 
3a and 3b, -ketoimines 5b-h were obtained in good to 
excellent yields ranging from 62 to 98% yield. An 
acceptable yield of 50% was obtained using the less 
nucleophilic p-nitroaniline to give the expected -
ketoimine 5i. Substituents on the aromatic ring on the C-
2 position of the benzofuran nucleus were also permitted 
as it could be observed with -ketoimines 5j,k (75 and 
86%, respectively). However, when mixing 4-
methoxyaniline 2b with benzofurans having an electron-
withdrawing group on C5 (CO2Me) or having an alkyl 
chain (n-Bu) on C2, starting materials were found 
unchanged suggesting that Buchwald coupling-reactions 
failed and were not optimized with these benzofurans. 
We further investigated the influence of various aromatic 
amines, and were pleased to observe that heterocyclic 
amines as 4-aminoquinaldine, 9-methyl-9H-carbazol-3-
amine and 1-methyl-1H-indol-5-amine reacted well under 
 SCHEME 2. Substrate Scope of α-Ketoimines 5b-o Formation under Pd-Coupling Conditions in the Presence of 
NaOtBu 
 
these conditions with 2-aryl-3-iodobenzofurans 3a, 3b 
and 3d to furnish the expected ketoimines 5l-o in good 
yields. 
To gain some insight into the plausible mechanism of this 
unexpected ring-opening reaction, we next focused our 
attention on the role of NaOtBu, which seemed to be 
responsible of the benzofurans ring-opening. As depicted 
in Scheme 3, our current hypothesis favors a radical 
pathway. Beside the formation of 4-aminobenzofuran 4a 
through Buchwald-Hartwig coupling, we hypothesized 
that catalytic amounts of the radical species V• and tBuO• 
were formed together with NaI from the reaction between 
NaOtBu and 3-iodobenzofuran 3a.This hypothesis was 
assumed with regard to a previous report of 
Cuthbertson,10 which showed that reaction of an 
aryliodide with KOtBu alone in hot toluene generated 
tBuO• radicals. Note that the formation of V• is supported 
by the presence in the crude reaction of small amounts of 
2-phenylbenzofuran, which was detected by LC/MS at 
the end of the reaction. Then, a hydrogen abstraction 
from 3-aminobenzofuran 4a by a tBuO• radical would 
occur to give the resulting aminyl radical W•.11 This 
hypothesis involving W• radicals is supported by the 
identification through LC/MS analysis of a dimeric 
hydrazine W212 (m/z of 819.3082 ([M + H]+) and 
410.1577 ([M + 2H]2+), see SI). In agreement with a 
recent report by Zhou et al.,13 radical W• would furnish a 
peroxy radical X• species by oxidation in the air. This 
latter, would then undergo oxidation of aminyl radical W• 
giving hemiketal radicals Y•. A subsequent 
monoelectronic ring-opening of Y• would furnish 
ketoimine Z•, which after hydrogen traping from tBuOH 
led to ketoimine 5a and regenerated tBuO• radical. This 
mechanistic hypothesis is also supported by Lavanya and 
Yamuna’s works, which previously reported that 3-
aminobenzofurans were excellent antioxidants agents 
able to trap free radicals.14  
In order to determine the origin of the oxygen atom of 
ketoimine 5a, we then carried out the Buchwald coupling 
reaction of 2a with 3a in an oxygen-free glove box (O2 
<0.2 ppm) using NaOtBu as the base. Under these 
conditions, the unstable diarylamine intermediate 4a was 
detected (NMR and LC/MS) as the main product in the 
crude mixture, and no trace of the ketoimine 5a was 
observed (absence of phenolic proton). This result 
demonstrated that the amount of O2 (air atmosphere or 
dissolved in toluene) at the beginning of the Buchwald 
reaction in the Schlenk tube was enough to promote the 
benzofuran ring-opening of 4a.  
To get more insight into the radical-involving reaction 
pathway, control experiments were achieved in order to 
trap any radical species. To this end, 2a and 3a were 
reacted under standard conditions in the presence of 
radical traps (TEMPO or galvinoxyl, Scheme 4). 
Unfortunatly, the presence of TEMPO or galvinoxyl shut 
down completely the Buchwald coupling reaction as 
starting materials were recovered unchanged. We then 
asked ourselves whether an external tBuO• radical source 
could (i) accelerate the formation of 5a when the reaction 
was conducted in the presence of NaOtBu or (ii) allow 
obtaining 5a when the reaction was carried out in the 
presence of Cs2CO3. As depicted in Scheme 4, by adding 
in the mixtures ditbutylperoxide (DTBP, 5 equiv) again, 
the Buchwald coupling reaction did not occur as starting  
 SCHEME 3. Possible Mechanism Leading to Ketoimine 5a 
 
 
materials 2a and 3a were mainly found unchanged. All 
these experiments indicate that additives such as radical 
traps or external sources of tBuO• are not welcome in the 
Schlenk tube at the beginning of the coupling reaction.15 
To demonstrate that 5a was formed from 4a in this novel 
process, a series of assays (reagents in blue, Scheme 4)  
were next performed from 4a, previously prepared using 
Cs2CO3 as the base. First, to determine if molecular 
oxygen was able to promote the benzofuran ring-opening 
of 4a, this latter was stirred under an O2 atmosphere in 
hot toluene (TLC control). Accordingly, 4a was slowly 
and totally consumed after 16 h of stirring in the Schlenk 
tube to furnish 5a but with a low yield of 28% together 
with many unidentified by-products. This result shows 
that molecular oxygen is not the only one responsible for 
the opening of benzofuran ring. 
Since the source of bases played a crucial role in this 
process, diarylamine 4a was mixed with NaOtBu (5 
equiv) in hot toluene. After 16 h of reaction at 140 °C, no 
trace of 5a was detected, clearly indicating that NaOtBu 
alone is not able to transform 4a into 5a. Next, we were 
interested to examine the behaviour of benzofuran 4a in 
the presence of DTPB. We were very pleased to observe, 
after only 3 h of reaction, the transformation of 4a into 
5a in a good 65% yield by employing only 5 mol% of 
DTBP. This last result clearly supports that the 
mechanism described in Scheme 3 involving tBuO• 
radicals (generated from NaOtBu and 3-iodobenzofurans) 
is plausible. 
SCHEME 4. Mechanistic Investigations 
 
 
 CONCLUSION 
In summary, ring-opening of 3-aminobenzofuran 
derivatives 4 promoted by NaOtBu and O2 has been 
described. 3-Aminobenzofurans were prepared from the 
N-arylation reaction between aromatic amines and 3-
iodobenzofurans in the presence of Pd2dba3 and Cs2CO3 
in toluene at 140 °C. When NaOtBu was used as the 
base, 3-aminobenzofuran derivatives 4 were not isolated 
because they rapidly reacted with tBuO• radicals and O2 
to give, after benzofurans ring-opening, a series of novel 
-ketoimines 5 difficult to access by alternative routes. 
We believe that the ability of NaOtBu to promote in hot 
toluene, 3-aminobenzofuran ring-opening is of 
significant importance for the scientific community. 
EXPERIMENTAL SECTION  
General Information and Method. All reactions were 
carried out under an air atmosphere in dried glassware. 
When needed, non-aqueous reagents were transferred via 
syringe and dried prior to use. Toluene anhydrous 
(99.8%) from Sigma-Aldrich (244511) was used and 
sodium tert-butoxide was flame dried under high vacuum 
for 5 minutes prior to use and stored under argon. Other 
solvents and reagents were used as obtained from 
supplier, unless otherwise noted. Analytical TLC was 
performed using Merck silica gel F254 (230-400 mesh) 
plates and analyzed by UV light or by staining upon 
heating with vanillin solution. For silica gel 
chromatography on column, the chromatography 
technique was used, with Merck silica gel 60 (230-400 
mesh) and p.a. grade solvents. 
The 1H NMR and 13C NMR spectra were recorded in 
either CDCl3 on Bruker Avance 300 spectrometer. The 
chemical shifts of 1H NMR spectra are reported in ppm 
relative to the solvent residual peak in CDCl3 (δ 7.26) for 
1H NMR. For the 13C NMR spectra, the solvent signals of 
CDCl3 (δ 77.16) were used as the internal standard.IR 
spectra were measured on a Bruker Vector 22 
spectrophotometer. MS were recorded on a Micromass 
spectrometer. Analytical TLC was performed on Merck 
pre-coated silica gel 60F plates. Merck silica gel 60 
(0.015–0.040 mm) was used for column chromatography. 
Melting points were recorded on a Büchi B-450 
apparatus and were uncorrected. High resolution mass 
spectra (HR-MS) were recorded on a MicroMass LCT 
Premier Spectrometer, using ESI or APCI with methanol 
as the carrier solvent. 
General Procedure for the synthesis of 3a-e and 
characterization data 
Suitable o-methoxydiarylalkyne (2 mmol, 1 equiv) was 
dissolved in dichloromethane (30 mL). To this solution 
was added iodine (3 mmol, 1.5 equiv), and the mixture 
was stirred at room temperature for 1 hour. The mixture 
was treated with saturated aqueous sodium thiosulfate 
(30 mL) and the product was extracted with 
dichloromethane (2×30 mL). The combined organic 
extracts were washed with water and dried over 
anhydrous sodium sulfate. The drying agent was removed 
by filtration, and the solvent was removed in vacuo 
leaving a crude solid. The solid was purified on silica gel 
chromatography (cyclohexane/ethyl acetate = 1/10) to 
afford the corresponding product 3. 
3-Iodo-6,7-dimethoxy-2-phenylbenzofuran (3a): 
1.56 g, 88% yield, light brown solid; mp 92.7 - 93.5°C; 
1H NMR (300 MHz, CDCl3) δ 8.17 (d, J = 7.3 Hz, 2H), 
7.49 (t, J = 7.3 Hz, 2H), 7.41 (t, J = 7.3 Hz, 1H), 7.04 (d, 
J = 8.5 Hz, 1H), 6.98 (d, J = 8.6 Hz, 1H), 4.24 (s, 3H), 
3.95 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 152.3, 149.7, 
145.6 134.1, 130.0 (2), 129.1, 128.5 (2), 127.2 (2), 114.9, 
110.0, 61.2, 61.0, 57.3; HRMS (ESI-TOF) m/z [M + H]+ 
calcd for C16H14IO3 380.9988, found 380.9982; IR film 
νmax/cm-1 : 3057, 2998, 2932, 1622, 1591, 1503, 1485, 
1463, 1485, 1446, 1304, 1292, 1253, 1090. 
3-Iodo-6,7-dimethoxy-2-(4-methoxyphenyl)benzofuran 
(3c): 
0.96 g, 62% yield, brown solid; mp 85.4 - 87.2 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.09 (d, J = 9.0 Hz, 2H), 7.02 
(m, 4H), 4.22 (s, 3H), 3.94 (s, 3H), 3.87 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 160.2, 155.2, 153.0, 149.5, 
145.4, 128.8 (2), 128.5, 122.6, 114.6, 113.9 (2), 109.9, 
61.0, 59.4, 57.3, 55.4; HRMS (ESI-TOF) m/z [M + Na]+ 
calcd for C17H15INaO4 432.9913, found 432.9916;  IR 
film νmax/cm-1 : 2999, 2961, 2932, 2904, 2835, 1612, 
1580, 1506, 1495, 1439, 1418, 1277, 1257, 1231, 1160, 
1101, 1088. 
3-Iodo-6,7-dimethoxy-2-(p-tolyl)benzofuran (3d): 
0.86 g, 62% yield, white solid; mp 112.5 - 112.9°C; 1H 
NMR (300 MHz, CDCl3) δ 8.06 (d, J = 8.0 Hz, 2H), 7.31 
(d, J = 8.0 Hz, 2H), 7.05 (d, J = 8.5 Hz, 1H), 6.99 (d, J = 
8.5 Hz, 1H), 4.25 (s, 3H), 3.97 (s, 3H), 2.44 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 153.1, 149.6, 139.2 (2), 134.1, 
129.2 (2), 128.5, 127.2 (2), 122.6, 114.7, 109.9, 61.0, 
60.4, 57.3, 21.5; HRMS (ESI-TOF) m/z [M + Na]+ calcd 
for C17H15INaO3 416.9964, found 416.9955; IR film 
νmax/cm-1 : 3000, 2950, 2927, 2899, 2832, 1595, 1495, 
1458, 1439, 1423, 1272, 1255, 1236, 1163, 1093. 
3-Iodo-6,7-dimethoxy-2-(thiophen-3-yl)benzofuran (3e): 
0.22 g, 69% yield, white solid; mp 123.5 - 124.1 °C; 1H 
NMR (300 MHz, CDCl3) δ 8.16 (d, J = 3.0 Hz, 1H), 7.92 
(d, J = 5.0 Hz, 1H), 7.46 (dd, J = 5.0 Hz, J = 3.0 Hz, 1H), 
7.04 (d, J = 8.5 Hz, 1H), 6.99 (d, J = 8.6 Hz, 1H), 4.23 
(s, 3H), 3.96 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
150.6, 149.7, 145.2, 134.1, 131.1, 128.1, 126.2, 125.9, 
124.1, 114.6, 110.0, 61.0, 60.5, 57.2; HRMS (ESI-TOF) 
m/z [M + H]+ calcd for C14H12IO3S 386.9552, found 
386.9545; IR film νmax/cm-1 : 2950, 2943, 2887, 2802, 
1660, 1587, 1495, 1460, 1418, 1302, 1115, 1044. 
General Procedure for the synthesis of 5a-o and 
characterization data 
Benzofuran 3 (0.550 mmol, 1.10 equiv), aniline 2 (0.500 
mmol, 1.00 equiv), Pd2(dba)3 (0.025 mmol, 0.05 equiv), 
Xphos (0.050 mmol, 0.10 equiv), sodium tert-butoxide 
(2.50 mmol, 5.00 equiv) and toluene (5 mL) were added 
to a dried Sealed tube (30 mL) under air atmosphere. 
After the mixture was heated to 140°C and stirred for 16 
hours, it was cooled to room temperature. The mixture 
was diluted with ethyl acetate (10 mL), filtered through a 
celite pad and concentrated. The solid was purified on 
silica gel chromatography (cyclohexane/ethyl acetate = 
1/1] to afford the corresponding product 5. 
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-2-((2-
methylquinolin-4-yl)imino)-1-phenylethanone (5a): 
175 mg, 82% yield, yellow solid; mp 153.7 - 154.9 °C; 
1H NMR (300 MHz, CDCl3) δ 13.31 (s, 1H), 8.07 (d, J = 
8.3 Hz, 1H), 7.88 (d, J = 7.7 Hz, 1H), 7.72 (d, J = 7.3 Hz, 
2H), 7.64 (t, J = 7.6 Hz, 1H), 7.48 (t, J = 7.6 Hz, 1H), 
7.41 (t, J = 7.7 Hz, 1H), 7.23 (t, J = 7.7 Hz, 2H), 7.01 (d, 
J = 9.0 Hz, 1H), 6.72 (s, 1H), 6.49 (d, J = 9.0 Hz, 1H), 
 4.02 (s, 3H), 3.94 (s, 3H), 2.57 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 192.9, 171.54, 159.2, 157.8, 156.6, 
150.3, 148.4, 137.2, 135.0, 134.1, 130.0, 129.2 (2), 129.0 
(2), 128.7, 127.5, 125.9, 123.2, 120.9, 112.7, 112.2, 
103.8, 60.9, 56.3, 25.5; HRMS (ESI-TOF) m/z [M + H]+ 
calcd for C26H23N2O4 427.1658, found 427.1662; IR film 
νmax/cm-1 : 3332, 2934, 2840, 1735, 1669, 1601, 1512, 
1467, 1290, 1234, 1125, 1085. 
(Z)-2-(2-Hydroxyphenyl)-2-((4-methoxyphenyl)imino)-1-
phenylethanone (5b): 
152 mg, 92% yield, yellow solid; mp 157.2 -158.4 °C; 1H 
NMR (300 MHz, CDCl3) δ 13.73 (s, 1H), 7.81 (d, J = 7.4 
Hz, 2H), 7.54 (t, J = 8.4 Hz, 1H), 7.39 (m, 3H), 7.16 (d, J 
= 8.4 Hz, 1H), 7.10 (d, J = 8.4 Hz, 1H), 6.98 (d, J = 8.9 
Hz, 2H), 6.80 (t, J = 8.4 Hz, 1H), 6.72 (d, J = 8.9 Hz, 
2H), 3.72 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 195.3, 
169.4, 161.8, 157.8, 138.9, 134.7, 134.2, 133.5, 130.3, 
129.3 (2), 129.0 (2), 123.4 (2), 118.9, 118.2, 117.2, 114.1 
(2), 55.3; HRMS (ESI-TOF) m/z [M + H]+ calcd for 
C21H18NO3 332.1287, found 332.1290; IR film νmax/cm-
1 : 3372, 2928,2851, 1669, 1575, 1504, 1433, 1407, 
1125. 
(Z)-2-((3,5-Dimethoxyphenyl)imino)-2-(2-
hydroxyphenyl)-1-phenylethanone (5c): 
125 mg, 69% yield, yellow solid; mp 153.3 - 153.9 °C; 
1H NMR (300 MHz, CDCl3) δ 13.37 (s, 1H), 7.84 (d, J = 
7.5 Hz, 2H), 7.58 (t, J = 7.5 Hz, 1H), 7.42 (m, 3H), 7.28 
(s, 1H) 7.19 (d, J = 8.4 Hz, 1H),  7.12 (d, J = 8.4 Hz, 
1H), 6.82 (t, J = 7.5 Hz, 1H), 6.15 (s, 2H), 3.66 (s, 
6H);13C NMR (75 MHz, CDCl3) δ 194.3, 170.6, 161.83, 
160.9, 147.7, 142.1, 134.8, 134.6, 134.0, 130.7, 129.4 
(2), 129.0 (2), 119.0, 118.3, 117.0, 100.3 (2), 98.5, 55.3 
(2); HRMS (ESI-TOF) m/z [M + H]+ calcd for 
C22H20NO4 362.1392, found 362.1394; IR film νmax/cm-
1 : 3061, 2960, 2936, 1678, 1592, 1425, 1259, 1140. 
(Z)-2-((3,4-Dimethoxyphenyl)imino)-2-(2-
hydroxyphenyl)-1-phenylethanone (5d): 
112 mg, 62% yield, brown solid; mp 147.8 - 148.5 °C; 1H 
NMR (300 MHz, CDCl3) δ 13.68 (s, 1H), 7.83 (d, J = 7.3 
Hz, 2H), 7.55 (t, J = 7.3 Hz, 1H), 7.40 (m, 3H), 7.16 (dd, 
J = 8.2 Hz, J =  1.3 Hz, 1H), 7.11 (dd, J = 8.2 Hz, J =  
1.3 Hz, 1H), 6.80 (t, J = 7.6 Hz, 1H), 6.68 (d, J = 9.1 Hz, 
1H), 6.60 (m, 2H), 3.79 (s, 3H), 3.74 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 195.3, 169.6, 161.8, 148.9, 147.3, 
139.2, 134.8, 134.4, 133.6, 130.4, 129.3 (2), 129.0 (2), 
118.9, 118.3, 117.2, 114.3, 111.1, 106.3, 55.9 (2); 
HRMS (ESI-TOF) m/z [M + H]+ calcd for C22H20NO4 
362.1392, found 362.1387; IR film νmax/cm-1 : 3060, 
2957, 2933, 1678, 1673, 1594, 1466, 1305, 1263. 
(Z)-2-(2-Hydroxyphenyl)-1-phenyl-2-((3,4,5-
trimethoxyphenyl)imino)ethanone (5e): 
149 mg, 76% yield, yellow solid; mp 168.4 - 169.8 °C; 
1H NMR (300 MHz, CDCl3) δ 13.38 (s, 1H), 7.73 (d, J = 
7.6 Hz, 2H), 7.45 (t, J = 7.7 Hz, 1H), 7.31 (m, 3H), 7.08 
(d, J = 7.7 Hz, 1H), 7.01 (d, J = 7.7 Hz, 1H), 6.71 (t, J = 
7.7 Hz, 1H), 6.13 (s, 2H), 3.64 (s, 3H), 3.58 (s, 6H); 13C 
NMR (75 MHz, CDCl3) δ 195.1, 170.5, 161.8, 153.3 (2), 
141.9, 136.0, 134.9, 134.8, 134.0, 130.64, 129.4 (2), 
129.1 (2), 119.1, 118.4, 117.1, 99.8 (2), 61.0, 56.1 (2); 
HRMS (ESI-TOF) m/z [M + H]+ calcd for C23H22NO5 
392.1498, found 392.1497; IR film νmax/cm-1 : 3402, 
2939, 2837, 1736, 1677, 1589, 1504, 1466, 1233, 1127. 
(Z)-2-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)imino)-2-
(2-hydroxyphenyl)-1-phenylethanone (5f): 
131 mg, 73% yield, yellow solid; mp 196.2 - 197.4 °C; 
1H NMR (300 MHz, CDCl3) δ 13.03 (s, 1H), 7.21 (d, J = 
7.3 Hz, 2H), 6.92 (t, J = 7.6 Hz, 1H), 6.80-6.73 (m, 3H), 
6.53 (d, J = 7.6 Hz, 1H), 6.48 (d, J = 7.6 Hz, 1H), 6.16 (t, 
J = 7.6 Hz, 1H), 6.05 (d, J = 8.6 Hz, 1H), 5.99 (d, J = 3.2 
Hz, 1H), 5.91 (dd, J = 8.6 Hz, J = 3.2 Hz, 1H), 3.52 (s, 
4H); 13C NMR (75 MHz, CDCl3) δ 194.9, 169.6, 161.8, 
143.5, 141.9, 139.5, 134.7, 134.3, 133.6, 130.4, 129.4 
(2), 129.1 (2), 118.9, 118.3, 117.3, 117.2, 115.4, 111.4, 
64.2 (2); HRMS (ESI-TOF) m/z [M + H]+ calcd for 
C22H18NO4 360.1236, found 360.1240; IR film νmax/cm-
1 : 3359, 2981, 2934, 2874, 1674, 1595, 1503, 1450, 
1306, 1240, 1199, 1149, 1000. 
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-2-((4-
methoxyphenyl)imino)-1-phenylethanone (5g): 
192 mg, 98% yield, yellow solid; mp 168.4 - 169.7 °C; 
1H NMR (300 MHz, CDCl3) δ 14.15 (s, 1H), 7.79 (d, J = 
7.4 Hz, 2H), 7.51 (t, J = 7.4 Hz, 1H), 7.36 (t, J = 7.4 Hz, 
2H), 6.94 (d, J = 8.8 Hz, 2H), 6.86 (d, J = 9.0 Hz, 1H), 
6.68 (d, J = 8.8 Hz, 2H), 6.38 (d, J = 9.0 Hz, 1H), 3.96 
(s, 3H), 3.87 (s, 3H), 3.68 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 195.2, 169.0, 157.8, 156.8, 156.6, 139.0, 137.2, 
134.8, 134.4, 129.5 (2), 129.1 (2), 126.4, 123.6 (2), 114.3 
(2), 112.6, 103.1, 60.8, 56.1, 55.4; HRMS (ESI-TOF) m/z 
[M + H]+ calcd for C23H22NO5 392.1498, found 
392.1482; IR film νmax/cm-1 : 3452, 2984, 2360, 1737, 
1514, 1336, 1236, 1045. 
(Z)-2-((3-(Benzyloxy)-4-methoxyphenyl)imino)-2-(2-
hydroxy-3,4-dimethoxyphenyl)-1-phenyl ethanone (5h): 
216 mg, 87% yield, yellow solid; mp 135.6 - 136.6 °C; 
1H NMR (300 MHz, CDCl3) δ 14.10 (s, 1H), 7.76 (d, J = 
7.7 Hz, 2H), 7.53 (t, J = 7.2 Hz, 1H), 7.37 (m, 7H), 6.88 
(d, J = 8.9 Hz, 1H), 6.69 (d, J = 8.3 Hz, 1H), 6.60 (m, 
2H), 6.40 (d, J = 9.0 Hz, 1H), 4.98 (s, 2H), 3.98 (s, 3H), 
3.90 (s, 3H), 3.79 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
195.1, 168.9, 156.4, 147.7, 139.0, 134.6, 134.3, 129.3 
(2), 129.0 (2), 128.6 (2), 127.9, 127.2 (2), 126.3, 118.6, 
115.0, 112.4, 111.6, 110.3, 110.2, 108.5, 107.7, 103.0, 
70.8, 60.7, 56.0 (2); HRMS (ESI-TOF) m/z [M + H]+ 
calcd for C30H28NO6 498.1917, found 498.1909; IR film 
νmax/cm-1 : 3320, 2934, 2840, 1671, 1564, 1513, 1443, 
1416, 1399, 1225, 1159. 
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-2-((4-
nitrophenyl)imino)-1-phenylethanone (5i): 
102 mg, 50% yield; yellow cristal, mp 162.3 - 162.9 °C; 
1H NMR (300 MHz, CDCl3) δ 12.95 (s, 1H), 8.06 (d, J = 
8.9 Hz, 2H), 7.79 (d, J = 7.3 Hz, 2H), 7.60 (d, J = 7.3 Hz, 
2H), 7.42 (t, J = 7.8 Hz, 2H), 7.07 (d, J = 8.9 Hz, 2H), 
6.95 (d, J = 9.0 Hz, 1H), 6.47 (d, J = 9.0 Hz, 1H), 3.99 
(s, 3H), 3.93 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
193.5, 172.0, 158.4, 156.9, 152.6, 145.6, 137.7, 135.9, 
134.6, 130.0 (2), 129.8 (2), 127.9, 125.2 (2), 123.0 (2), 
112.4, 104.3, 61.3, 56.7; HRMS (ESI-TOF) m/z [M + 
H]+ calcd for C22H19N2O6 407.1243, found 407.1240; IR 
film νmax/cm-1 : 3394, 2936, 2849, 1624, 1513, 1448, 
1340, 1292, 1247, 1217, 1197, 1171. 
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-1-(4-
methoxyphenyl)-2-((4-methoxyphenyl)imino) ethanone 
(5j): 
181 mg, 86% yield, yellow solid; mp 210.4 - 211.9 °C; 
1H NMR (300 MHz, CDCl3) δ 14.29 (s, 1H), 7.79 (d, J = 
8.7 Hz, 2H), 6.99 (d, J = 8.7 Hz, 2H), 6.90 (d, J = 9.0 Hz, 
1H), 6.84 (d, J = 8.7 Hz, 2H), 6.72 (d, J = 8.7 Hz, 2H), 
6.39 (d, J = 9.0 Hz, 1H), 3.97(s, 3H), 3.89 (s, 3H), 3.82 
 (s, 3H), 3.71 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
193.2, 169.1, 164.7, 157.6, 156.5, 147.9, 138.9 (2), 131.9 
(2), 127.4, 126.3, 123.4 (2), 114.3 (2), 114.1 (2), 112.6, 
102.8, 60.7, 56.0, 55.5, 55.3; HRMS (ESI-TOF) m/z [M 
+ H]+ calcd for C24H24NO6 422.1604, found 422.1625; IR 
film νmax/cm-1 : 3422, 2934, 2838, 2360, 1666, 1659, 
1593, 1512, 1291, 1198, 1163, 1030. 
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-2-((3-
methoxyphenyl)imino)-1-(p-tolyl)ethanone (5k): 
158 mg, 75% yield, yellow solid; mp 187.6 - 187.9 °C; 
1H NMR (300 MHz, CDCl3) δ 14.29 (s, 1H), 7.79 (d, J = 
8.7 Hz, 2H), 6.99 (d, J = 8.7 Hz, 2H), 6.90 (t, J = 9.0 Hz, 
1H), 6.84 (d, J = 8.7 Hz, 2H), 6.72 (d, J = 8.7 Hz, 2H), 
6.39 (d, J = 9.0 Hz, 1H), 3.97(s, 3H), 3.89 (s, 3H), 3.82 
(s, 3H), 3.71 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
193.2, 169.1, 164.7, 157.6, 156.5, 147.9, 138.9 (2), 131.9 
(2), 127.4, 126.3, 123.4 (2), 114.3 (2), 114.1 (2), 112.6, 
102.8, 60.7, 56.0, 55.5, 55.3; HRMS (ESI-TOF) m/z [M 
+ H]+ calcd for C24H24NO5 406.1654, found 406.1657; IR 
film νmax/cm-1 : 3280, 3003, 2936, 2837, 2358, 1670, 
1602, 1584, 1564, 1512, 1290, 1249, 1236, 1145, 1127, 
1085. 
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-2-((2-
methylquinolin-4-yl)imino)-1-(p-tolyl)ethanone (5l): 
158 mg, 72% yield, off white solid; mp 237.5 - 238.5 °C; 
1H NMR (300 MHz, CDCl3) δ 13.38 (s, 1H), 8.09 (d, J = 
8.3 Hz, 1H), 7.88 (d, J = 8.3 Hz, 1H), 7.66 – 7.61 (m, 
3H), 7.48 (t, J = 7.9 Hz, 1H), 7.05 - 6.97 (m, 3H), 6.74 
(s, 1H), 6.45 (d, J = 7.7 Hz, 1H), 4.01 (s, 3H), 3.92 (s, 
3H), 2.57 (s, 3H), 2.24 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 192.2, 171.6, 159.1, 157.7, 156.5, 150.2, 148.3, 
146.4, 137.2, 131.5, 129.9, 129.7 (2), 129.2 (2), 128.5, 
127.4, 125.8, 123.1, 120.9, 112.5, 112.2, 105.2, 103.6, 
60.8, 56.1, 25.4, 21.8; HRMS (ESI-TOF) m/z [M + H]+ 
calcd for C27H25N2O4 441.1814, found 441.1817; IR film 
νmax/cm-1 : 3402, 3059, 2945, 2843, 2359, 1678, 1669, 
1583, 1500, 1465, 1448, 1321, 1304, 1241, 1104, 1069. 
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-2-((9-methyl-
9H-carbazol-3-yl)imino)-1-(p-tolyl) ethanone (5m): 
179 mg, 75% yield, yellow solid; mp 174.4 – 175.2 °C; 
1H NMR (300 MHz, CDCl3) δ 14.61 (s, 1H), 7.98 (d, J = 
7.7 Hz, 1H), 7.81 – 7.71 (m, 3H), 7.45 (t, J = 7.6 Hz, 
1H), 7.33 – 7.24 (m, 2H), 7.19 (d, J = 6.9 Hz, 2H), 7.10 
(d, J = 8.1 Hz, 2H), 6.93 (d, J = 9.0 Hz, 1H), 6.40 (d, J = 
9.0 Hz, 1H), 4.02 (s, 3H), 3.89 (s, 3H), 3.70 (s, 3H), 2.26 
(s, 3H); 13C NMR (75 MHz, CDCl3) δ 195.1, 168.5, 
156.6, 156.4, 145.9, 141.4, 139.1, 137.7, 137.1, 131.9, 
129.7 (2), 129.5 (2), 126.2, 126.1, 122.9, 122.5, 120.9, 
120.5, 119.0, 114.1, 112.8, 108.6 (2), 102.8, 60.7, 56.0, 
29.1, 21.8; HRMS (ESI-TOF) m/z [M + H]+ calcd for 
C30H27N2O4 479.1979, found 479.1974; IR film νmax/ 
cm-1 : 3202, 2934, 2839, 2359, 1666, 1609, 1588, 1511, 
1466, 1450, 1432, 1330, 1290, 1183, 1162, 981. 
(Z)-2-(2-Hydroxyphenyl)-2-((9-methyl-9H-carbazol-3-
yl)imino)-1-phenylethanone (5n): 
137 mg, 68% yield, yellow solid; mp 182.5 - 183.0 °C; 
1H NMR (300 MHz, CDCl3) δ 14.08 (s, 1H), 8.00 (d, J = 
7.7 Hz, 1H), 7.86 (d, J = 7.2 Hz, 2H), 7.80 (d, J = 1.8 Hz, 
1H), 7.47 – 7.41 (m, 2H), 7.36 – 7.30 (m, 4H), 7.25 – 
7.15 (m, 5H), 6.84 (t, J = 8.1 Hz, 1H), 3.73 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 196.0, 169.0, 162.0 (2), 141.6, 
139.8,  137.9, 134.7, 134.4, 133.5, 130.4, 129.4 (2), 
129.1 (2), 126.3, 123.0, 122.7, 121.0, 120.6, 119.2, 
118.9, 118.4, 117.6, 114.4, 108.8 (2), 29.3; HRMS (ESI-
TOF) m/z [M + H]+ calcd for C27H21N2O2 405.1603, 
found 405.1591; IR film νmax/cm-1 : 3264, 3002, 2856, 
1675, 1580, 1492, 1442, 1354, 1256, 1207.  
(Z)-2-(2-Hydroxy-3,4-dimethoxyphenyl)-2-((1-methyl-
1H-indol-5-yl)imino)-1-phenylethanone (5o): 
149 mg, 72% yield, yellow solid; mp 147.5 - 147.9 °C. 
1H NMR (300 MHz, CDCl3) δ 14.58 (s, 1H), 7.83 (d, J = 
8.0 Hz, 2H), 7.46 (t, J = 7.0 Hz, 1H), 7.33 (t, J = 7.7 Hz, 
2H), 7.28 (d, J = 2.0 Hz, 1H), 7.12 (d, J = 8.7 Hz, 1H), 
7.01 – 6.95 (m, 2H), 6.90 (d, J = 9.0 Hz, 1H), 6.40 (d, J = 
9.1 Hz, 1H), 6.37 (d, J = 2.0 Hz, 1H), 4.00 (s, 3H), 3.90 
(s, 3H), 3.69 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
195.3, 167.7, 156.3, 156.1, 137.8 (2), 134.7, 134.1, 
134.0, 129.4, 129.0 (2), 128.6 (2), 128.1, 125.8, 117.0, 
113.8, 112.4, 109.2, 102.5, 101.1, 60.4, 55.7, 32.6; 
HRMS (ESI-TOF) m/z [M + H]+ calcd for C25H23N2O4 
415.1658, found 415.1657; IR film νmax/cm-1 : 3445, 
2936, 2840, 2360, 1670, 1614, 1592, 1484, 1292, 1222, 
1125, 1085. 
General Procedure for the synthesis of 1a-c and 
characterization data 
Benzofuran 3 (0.750 mmol, 1.5 equiv), aniline 2a (0.500 
mmol, 1.00 equiv), Pd2(dba)3 (0.025 mmol, 0.05 equiv), 
Xphos (0.050 mmol, 0.10 equiv), cesium carbonate (1.1 
mmol, 2.20 equiv) and toluene (5 mL) were added to a 
dried Schlenk tube (30 mL) under air atmosphere. After 
the mixture was heated to 130°C and stirred for 16 hours, 
it was cooled to room temperature. The mixture was 
diluted with ethyl acetate (10 mL), filtered through a 
celite pad and concentrated. Dry DMF (5 mL) was added 
to the resulting solid and the mixture was cooled to 0°C. 
Sodium hydride (2.5 mmol, 5 equiv) was added and the 
mixture was stirred at 0°C for 30 min. Methyl iodide was 
added slowly and the crude mixture was stirred at r.t. for 
2h. Water (5 mL) was added slowly and the product was 
extracted with ethyl acetate (3x10 mL). The combined 
organic extracts were dried over anhydrous sodium 
sulfate. The drying agent was removed by filtration, and 
the solvent was removed in vacuo leaving a crude solid. 
The solid was purified on silica gel chromatography 
(cyclohexane/ethyl acetate = 1/1) to afford the 
corresponding product 1.  
N-(6,7-Dimethoxy-2-phenylbenzofuran-3-yl)-N,2-
dimethylquinolin-4-amine (1a): 
100 mg, 47% yield, off white solid; mp 204.6 - 205.1 °C; 
1H NMR (300 MHz, CDCl3) δ 8.02 (d, J = 7.8 Hz, 2H), 
7.82 (d, J = 8.8 Hz, 2H), 7.38 (m, 3H), 7.29 (t, J = 7.8 
Hz, 1H), 6.97 (t, J = 7.8 Hz, 1H), 6.90 (s, 1H), 6.48 (d, J 
= 8.8 Hz, 1H), 6.22 (d, J = 8.8 Hz, 1H), 4.16 (s, 3H), 
3.72 (s, 3H), 3.37 (s, 3H), 2.68 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 158.9, 152.8, 149.3, 146.2, 145.0, 134.6, 
129.7, 129.0, 128.9 (3), 128.4, 127.4, 125.2 (2), 124.4, 
123.3, 122.2, 121.1, 112.6, 110.0, 109.7, 107.5, 61.0, 
57.0, 41.6, 25.7; HRMS (ESI-TOF) m/z [M + H]+ calcd 
for C27H25N2O3 425.1865, found 425,1872; IR film 
νmax/cm-1 : 2932, 2837, 1736, 1619, 1562, 1507, 1296, 
1267, 1091, 1069; HPLC [H2O, 0.1% ac. form. / ACN – 
gr 5-100% - 20 min] r. t. : 12.52 min., purity : 100%. 
N-(6,7-Dimethoxy-2-(p-tolyl)benzofuran-3-yl)-N,2-
dimethylquinolin-4-amine (1b): 
77 mg, 35% yield, off white solid; mp 254.7 - 254.9 °C; 
1H NMR (300 MHz, CDCl3) δ 8.76 (d, J = 8.6 Hz, 1H), 
7.90 (d, J = 8.6 Hz, 1H), 7.68-7.62 (m, 3H), 7.25 (d, J = 
8.1 Hz, 2H), 7.17 (t, J = 8.1 Hz, 1H), 6.95 (s, 1H), 6.81 
 (d, J = 8.6 Hz, 1H), 6.57 (d, J = 8.6 Hz, 1H), 4.28 (s, 
3H), 3.90 (s, 3H), 3.72 (s, 3H), 3.11 (s, 3H), 2.39 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 157.2, 154.4, 149.9, 148.0, 
140.1, 139.7, 135.7, 132.9, 131.4 (2), 130.0, 126.6, 125.3 
(2), 124.1, 121.0, 120.3, 118.2, 111.4, 110.5, 108.5, 
105.3, 89.9, 61.1, 57.1, 43.7, 21.5, 20.6; HRMS (ESI-
TOF) m/z [M + H]+ calcd for C28H27N2O3 439.2022, 
found 439.1989; IR film νmax/cm-1 : 2863, 2788, 1633, 
1590, 1506, 1439, 1403, 1383, 1268, 1225, 1101, 1091; 
HPLC [H2O, 0.1% ac. form. / ACN – gr 5-100% - 20 
min.] r.t. : 13.22 min., purity: 100%. 
N-(6,7-Dimethoxy-2-(thiophen-3-yl)benzofuran-3-yl)-
N,2-dimethylquinolin-4-amine (1c): 
84 mg, 39% yield, white solid; mp 248.2 - 248.6 °C; 1H 
NMR (300 MHz, CDCl3) δ 7.90 (d, J = 8.4 Hz, 1H), 7.74 
(d, J = 8.4 Hz, 1H), 7.52 (d, J = 4.0 Hz, 1H), 7.41 (t, J = 
7.7 Hz, 1H), 7.31 (d, J = 4.0 Hz, 1H), 7.05 (t, J = 4.0 Hz, 
1H), 7.00 (t, J = 7.7 Hz, 1H), 6.88 (s, 1H), 6.54 (d, J = 
8.5 Hz, 1H), 6.31 (d, J = 8.5 Hz, 1H), 4.15 (s, 3H), 3.74 
(s, 3H), 3.42 (s, 3H), 2.70 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 158.3, 153.6, 149.5, 148.0, 145.0, 144.3, 134.6, 
130.6, 129.6, 127.8 (2), 126.8, 125.3, 125.1, 124.7, 
123.5, 121.7, 120.6, 112.1, 109.8, 107.4, 61.0, 57.0, 
41.8, 25.1; HRMS (ESI-TOF) m/z [M + H]+ calcd for 
C25H23N2O3S 431.1429, found 431.1432; IR film 
νmax/cm-1 : 2854, 2776, 1642, 1604, 1515, 1430, 1394, 
1392, 1276, 1112, 1083; HPLC [H2O, 0.1% ac. form. / 
ACN – gr 5-100% - 20 min] r. t.: 12.13 min., purity: 
96%. 
SUPPORTING INFORMATION AVAILABLE: 1H 
and 13C NMR spectra of new compounds. This material 
is available free of charge via the Internet at 
http://pubs.acs.org. 
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